Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds

Advertising today archive

3104 PWToday Stories

Upstream and McGill join hands on testing of tropical disease treatments

11 Jul 08

Upstream Biosciences has entered into collaboration with McGill University's Institute of Parasitology in Montreal, Canada to begin in vitro testing of the company's second generation of drug candidates for the potential treatment of tropical diseases leishmaniasis, trypanaosomiasis and malaria.

Upstream's proprietary drug discovery platform utilizes chemoinformatics which combines chemistry and computer-aided design to accelerate the speed and reduce the cost of discovering drugs to treat disease. Testing at McGill's Institute of Parasitology will be directed by Armando Jardim

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.